Dr. Hyo-Soo Kim and I discussed the HOST-BR trial on optimal DAPT duration and thrombosis-bleeding balance in ACS patients. 3-month DAPT reduced thrombosis vs. 1-month in high bleeding risk, and reduced bleeding vs. 12-month in low-risk patients March 29, 2025 Disclosures: TBD
Dr. Keyvan Karkouti and I discussed the FARES-II trial. PCC is superior to FP for hemostasis in managing excessive bleeding among cardiac surgery ptS with coagulopathy. March 29, 2025 Disclosures: TBD
Dr. Marc Bonaca and I discussed the STRIDE trial. Semaglutide improves functional outcomes in DM pts with symptomatic PAD, addressing a critical unmet need. March 29, 2025 Disclosures: TBD
THIS WEEK IN OBESITY: Gibson and Dr. Perreault discuss the possibility or lack thereof that we can prevent and/or reverse diabetes and obesity. March 6, 2025
THIS WEEK IN OBESITY: Dr. Gibson and Dr. Perreault discuss the concept that there may or may not be an obesity set point throughout various stages of life. March 4, 2025
Dr. Gibson and Dr. Perreault discuss her PATHWEIGH study for pragmatic weight management in primary care. February 28, 2025
THIS WEEK IN NEPHROLOGY: Dr. Parikh and I discuss the definition and implementation of the Four Pillars of Care in patients with renal insufficiency. February 26, 2025
THIS WEEK IN NEPHROLOGY: Dr. Parikh and I discuss exciting new developments Xenotransplantation for patients with renal insufficiency. February 26, 2025
Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson discuss best practices for titration of GLP-1 medications for optimal weight loss. February 17, 2025 Disclosures: TBD
Dr. McGuire, Dr. Jastreboff, and Dr. C. Michael Gibson explore the question of what is the right weight reduction for each patient taking GLP-1 medications? February 12, 2025 Disclosures: TBD
